Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Veracyte Inc (NASDAQ:VCYT)

7.49
Delayed Data
As of 4:00pm ET
 -0.09 / -1.19%
Today’s Change
4.21
Today|||52-Week Range
8.45
+4.03%
Year-to-Date
No recent news for Veracyte Inc.

Today’s Trading

Previous close7.58
Today’s open7.36
Day’s range7.33 - 7.72
Volume115,118
Average volume (3 months)102,578
Market cap$249.1M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+4.41%
Earnings growth (this year)+3.75%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.62%
P/E ratioNM
Price/Sales3.78
Price/Book4.09

Competitors

 Today’s
change
Today’s
% change
OXFDOxford Immunotec Glo...+0.27+1.84%
TRIBTrinity Biotech PLC+0.04+0.58%
LNTHLantheus Holdings In...+0.15+1.61%
QTNTQuotient Ltd-0.10-1.90%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$49.5M
Annual profit (last year)-$33.7M
Net profit margin-68.08%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bonnie H. Anderson
Chief Operating Officer
Christopher M. Hall
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs